Associate Scientist II, Injectable Drug Product Dev

Alexion Pharma Spain S.L.; New Haven (CT); On-site; USD 75,000 - 110,000; Full time

Job summary

Alexion-AstraZeneca Rare Disease in New Haven, CT is seeking an Associate Scientist II for the Injectable Drug Product Development (IDPD) team. The role focuses on formulation and process development for clinical biologics, with hands-on experimentation and collaboration across functions.

You will design studies, perform physico-chemical characterization and stability assessments, and document findings in clear technical reports.

Qualifications

• BS or MS in Biochemistry, Pharmaceutical Science, Chemical Engineering, or related field.
• 2–4 years of experience in pharma/biotech.
• Knowledge of protein/peptide biochemistry, formulation, and stability.
• Experience with iCE, HPLC/UPLC, DLS, CD, DSC, AUC, and NanoTemper.
• Ability to work with minimal supervision in a collaborative setting.
• Excellent communication and problem-solving skills.
• Proficient with MS Office and electronic record systems.

Responsibilities

• Design and execute formulation and process development studies for clinical candidates.
• Execute drug development studies including physico-chemical characterization and stability assessments.
• Characterize conformational and colloidal stability using standard methods.
• Maintain organized records and prepare internal development reports.
• Participate in cross-functional development teams.

Skills

Interpersonal skills

Communication

MS Office proficiency

Collaboration

Lab skills

Education

BS/MS in Biochemistry/Pharmaceutical Science

Tools

iCE/Maurice

HPLC/UPLC

DLS

CD

DSC

AUC

NanoTemper

Job description

Alexion-AstraZeneca Rare Disease in New Haven, CT is seeking an Associate Scientist II for the Injectable Drug Product Development (IDPD) team. The role focuses on formulation and process development for clinical biologics, with hands-on experimentation and collaboration across functions.

You will design studies, perform physico-chemical characterization and stability assessments, and document findings in clear technical reports.